Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Parabon Nanolabs
AddedFeb 15, 2024
UpdatedJun 18, 2026
Parabon Nanolabs

Parabon Nanolabs

Angel

Parabon NanoLabs: A Virginia-based DNA tech firm specializing in nanopharmaceuticals and DNA phenotyping.

HQ
Reston, VA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Parabon NanoLabs, founded in 2008 by Steven Armentrout, Michael Norton, and Christopher Dwyer, is a DNA technology company based in Reston, Virginia. The company specializes in developing nanopharmaceuticals and providing DNA phenotyping services for law enforcement. Their core mission is to harness the power of DNA to create innovative solutions in both medical and forensic fields. Parabon offers products like the inSēquio Design Studio for DNA nanotechnology research and forensic DNA analysis services.

Notable figures affiliated with Parabon NanoLabs include Steven Armentrout, who has served as the CEO and President of its parent company, Parabon Computation. The company has made significant strides in oncology and forensic science, providing groundbreaking tools that aid in criminal investigations and medical research. Parabon's impact is evident in its contributions to solving cold cases and advancing personalized medicine through its cutting-edge DNA technologies.

Parabon Nanolabs - Similar Companies

Othram logo

Othram

othram.com

Perez Forensic Strategies logo

Perez Forensic Strategies

Ande logo

Ande

ande.com

BNB Plus logo

BNB Plus

adnas.com

Dnanexus logo

Dnanexus

dnanexus.com

Nanopath logo

Nanopath

nanopathdx.com

Paragon Genomics logo

Paragon Genomics

Natera logo

Natera

natera.com

23andMe logo

23andMe

23andme.com

NMS Labs logo

NMS Labs

nmslabs.com

Paradise Genomics logo

Paradise Genomics

NantOmics logo

NantOmics

nantomics.com

NanoMosaic logo

NanoMosaic

Nanomatronix logo

Nanomatronix

nanomatronix.com

NanoCytomics logo

NanoCytomics

nano-cytomics.com

Parabon Nanolabs - Quick Facts

Who are Parabon Nanolabs' competitors?

Companies similar to Parabon Nanolabs include Othram, Perez Forensic Strategies, Ande and BNB Plus.

When was Parabon Nanolabs founded?

Parabon Nanolabs was founded in 2008.

Where is Parabon Nanolabs' headquarters located?

Parabon Nanolabs' headquarters is located in Reston, VA, US.

When was Parabon Nanolabs' last funding round?

Parabon Nanolabs' most recent funding round was for $150k (USD) in May 2014.

How much has Parabon Nanolabs raised to-date?

As of May 20, 2014, Parabon Nanolabs has raised a total of $150k (USD).

How many employees does Parabon Nanolabs have?

Parabon Nanolabs has 30 employees as of Feb 4, 2024.

Parabon Nanolabs - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • DNA Testing
  • Nanopharmaceuticals
Tags
  • Biotech
  • GenAI
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2011Manufacture of basic chemicals
Show 4 more industry codes
NAICS
  • 325100Basic Chemical Manufacturing
  • 325120Industrial Gas Manufacturing
SIC
  • 2860Industrial Organic Chemicals
  • 2869Industrial Organic Chemicals, Not Elsewhere Classified